The antiviral therapies remdesivir, molnupiravir, and the active ingredient in Pfizer’s Paxlovid pill (nirmatrelvir), remain effective in laboratory […]
If truth is the first casualty of war, the second is health and wellbeing. BMJ condemns Russia’s war […]
The government’s planned ‘Road to Recovery’ will have a new focus on prevention
Certain areas in the UK have been experiencing a significant increase in COVID-19 cases in recent days
AbbVie touts Qulipta chronic migraine win as Biohaven duel heats up aliu Thu, 03/10/2022 – 10:34
COVID-19 tracker: Africa close to getting Pfizer’s pill; Moderna progresses omicron-specific booster trial admin Tue, 01/04/2022 – 09:42
Zydus hit with trio of FDA observations at Indian injectables plant fkansteiner Thu, 03/10/2022 – 11:02
Novartis puts contract manufacturing ambitions on display with deal to produce Carisma’s cell therapy fkansteiner Thu, 03/10/2022 – […]
Pfizer is halting investment in Russia but not ending its business there. Should drugmakers pull out altogether? kdunleavy […]
New research has identified that the frequently used chemotherapy drug (5-FU or Fluorouracil) is 100 per cent more […]